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Cutaneous Lesion Associated with Multiple Endocrine Neoplasia
Type 2A: Lichen Amyloidosis or Notalgia Paresthetica?

O. Chabre,* F. Labat,^ N. Pinel,^ F. Berthod,* V. Tarel,^ and I. Bachelot*

Three patients ofa French family demonstrated an association of multiple endocrine neoplasia type
2A (MEN 2A) with a pruritic scapular skin lesion. The lesions are similar to those described as
famUial cutaneous lichen amyloidosis in unrelated MEN 2A and medullary thyroid carcinoma
families, but histological, immunohistochemical, and ultrastructural analysis of skin biopsies from
each patient in the French family did not show amyloid deposition. The topography of the lesion
follows dermatomes C8-D3. The patients report not only pruritus but also paresthesia and hyperalgesia, and one showed touch hypoesthesia and pain hyperesthesia in the area ofthe lesion. Such
an association of cutaneous and neurological features suggests notalgia paresthetica (NP), a
neuropathy ofthe posterior dorsal rami nerves. We thus suggest that the cutaneous lesions associated
with MEN 2A might be secondary to pathology in the neural crest-derived dorsal sensory nerves. The
amyloid, when present, would be secondary to scratching. We propose that patients presenting with
familial NP be suspect for MEN 2A. (Henry Ford Hosp MedJ 1992;40:245-8)

M

ultiple endocrine neoplasia type 2A (MEN 2A) is a genetic disease consisting of medullary thyroid carcinoma
(MTC), pheochromocytoma, and parathyroid hyperplasia. Its
gene has been recently assigned to the pericentromeric region of
chromosome 10(1-3), as have the genes forthe related MEN 2B
and familial MTC syndromes (3,4). Since 1989, a new clinical
manifestation has been described in three families, two with
MEN 2A (5,6) and one with MTC only (7). The manifestation
consists of pruritus in the scapular area, with or without an associated skin lesion. The finding of amyloid deposits in the papillary dermis in some of these lesions (6-9) led to a diagnosis of
cutaneous lichen amyloidosis (CLA), a rare derinatological disease which exists both in sporadic and famdial (FCLA) forms.
The genetic linkage of this variety of FCLA to the MEN 2 locus
has recently been demonstrated (10). We report a French MEN
2A family in which three patients present with the same type of
pruritic scapular skin lesions, but also mention paresthesia and
hyperalgesia in the same area. Despite extensive analysis of
three skin biopsies per patient, no amyloid deposits were found.
We di.scuss a new hypothesis on the pathogenesis of this cutaneous manifestafion associated with MEN 2A.

Materials and Methods
Patients
Family A (11) was identified in 1981 when the propositus
(III-10, Fig 1) presented with MTC, pheochromocytoma, and
hyperparathyroidism. His mother had paroxysmal hypertension
and died at age 36 during surgery for uterine leiomyoma.
For the screening the family was divided in three groups as
shown in the pedigree (Fig 1). In group 1 the screening procedure included physical examination and the following measure-
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ments: serum calcitonin (CT) (first by RIA [Mallincrodt] and
later by an immunoradiometric assay [CIS]) during stimulation
by pentagastrin; serum calcium, phosphate, and parathormone;
and urinary catecholamines and methoxamine levels. Nine subjects were screened and five new patients diagnosed with MTC
(three of whom had pheochromocytomas initially with a later
diagnosis in the other two) and four with hyperparathyroidism.
From 1989 to 1991, risks for carrying the MEN 2A gene were
assessed in the other subjects by linkage analysis performed by
the lARC (Lyon) using restriction fragment-length polymorphisms generated with genetic probes linked to the MEN 2A
gene locus (12) by which two (IV-2 and IV-7) were shown to be
at high risk of carrying the MEN 2A gene. Patient IV-2 later was
found lo have MTC and patient IV-7 was found to have slighdy
elevated stimulated CT levels. These five patients and the propositus had surgery. Three had micrometastases, including the
propositus who eventually developed diffuse MTC metastases.
In groups 2 and 3 (Fig 1) all subjects (except one) were
screened by measurement of serum CT (CIS), basal (subjects >
65 years old) and pentagastrin stimulation (subjects < 65 years
old) levels. None of these subjects had abnormal results. A l -
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Pig 1—Genealogy and screening results offamily A. Blank circle = females, blank squares = males, solid .square = MTC 4- pheochromocytoma 4- parathyroid hyperplasia, box with dark screen = suhject at high risk of canying the MEN 2A gene (genetic and/or
CT screening), box with light screen = subject at low risk of carrying MEN 2A gene (genetic and/or CT screening), square with diagonal line = deceased suhject, shaded circle with diagonal line = suspicion of death by pheochromocytoma, half-filled circle = MTC,
quarter-filled square = MTC -b pheochromocytoma, * = cutaneous lesion,'.'= unscreened suhject.
though the MEN 2A gene was probably transmitted by the
mother of the propositus, no evidence of MEN 2A could be
found in either the maternal or patemal relatives.
Dermatopathologic study
All subjects were questioned about the presence of dorsal
pruritus. Subjects in group 1 also underwent physical examination. Three punch biopsies were performed in each patient with
scapular skin lesions. One biopsy was fixed in Bouin solution,
embedded in paraffin, and stained with hematoxylin eosin,
Congo red, or thiofiavin T. The second biopsy was fixed first in
2.5% glutaraldehyde, then in 1% osmium tetroxide and embedded in Epon for ultrastructural study. The third biopsy was processed for immunohistochemical studies on frozen sections.
Antibodies were selected to study the following components:
immunoglobulin deposits, complement and fibrinogen, colloid
bodies, keratins, amyloid deposits, and immunologic phenotypes of lymphocytic infiltrates.
Neurological investigations
Patient IV-2 had a thorough neurological examination, an
electromyographic study of dorsal roots C8 to D3, and a magnetic resonance imaging (MRI) study of the cervicothoracic
spine.

Results
Clinical cutaneous and neurological manifestations
None of the subjects without MEN 2A had scapular pruritus
or skin lesions. None of the deceased subjects was known to
have complained of pruritus. Two male patients (III-10,49 years
old; III-11,43 years old) and one female patient (IV-2, 20 years
old) presented with chronic pruritic manifestation in the same
specific area (Fig 2). This area was located in the upper back, at
the level of the 1st to the 4th thoracic vertebra, along the midline
and extending to the left (III-10) or the right (III-11, IV-2) scap-

246

Henry Ford Hosp Med J—Vol 40, Nos 3 & 4, 1992

ular region. The symptomatology appeared at 11 years of age
(patient IV-2) or about 16 years (patients III-10 and III-l 1) and
preceded the lesion. In all three patients pruritus was described
as paroxysmal and was associated with hyperalgesia, buming,
and sometimes tingling. The symptomatology was much more
intense for patient IV-2 than for patients III-10 and III-l 1. The
lesions were restricted to the pruritic zone and showed in all patients a brown patch of macules. However, lesion characteristics
were variable: the lesion of patient IV-2 (Fig 2B) showed lichenified papules in addition to the macules, whereas in patient
III-10 (Fig 2A) hyperpigmentation of the epidermis and the hair
was prominent. The lesion of patient l l l - l 1 (not shown) was discrete.
The neurological examination of patient lV-2 showed hypoesthesia for light touch and hyperesthesia for pinprick in an area
restricted to the skin lesion and its periphery. No other sensory
or motor abnormality could be elicited, and the electromyogram
and MRI were considered nonnal.

Histology
The morphological features were similar in all three patients,
although more prominent in patient IV-2. The epidermis
showed moderate acanthosis, focal hyperpigmentation, and hyperplasia of the basal layer, but no immunoreactivity for 56 kd
keratins. No colloid bodies were seen. The dermo-epidermal
junction showed segmentary thickenings facing acellular areas
ofthe papillary dermis. The dermis showed a pigmentary incontinence and a perivascular lymphohistocytic infiltrate with a
predominantly T8 phenotype. The ultrastructural study confirmed the alterations of the dermo-epidermal junction: reticular
aspect of the lamina densa with destruction ofthe hemi-desmosomes. Immunohistochemical study showed no deposit of IgG
but a deposit of C3 at the dermo-epidermal juncfion.
No amyloid deposit could be shown by either the special
stainings or by ultrastructural or immunohistochemical study.
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Discussion
The clinical cutaneous features of the three French pafients
reported here are similar to those reported earlier in two MEN
2A and one familial MTC families (5-7). The remarkable topography of the pruritus is identical: upper back at the level of the
first thoracic vertebras extending unilaterally to the right or left
scapular regions. This pruritus preceded the appearance of a
similar hyperpigmented skin lesion, also lichenified in patient
lV-2 who had the most intense scratching. These similarities
strongly suggest that the patients of all four families have the
same skin pathology. As in the other families, all three French
padents presenting with this skin pathology also have MEN 2A,
consistent with the recent demonstration that it is genetically
linked to the MEN 2 locus (10). As in two other famdies (6,7),
some French patients do have MEN 2 A but no scapular pruritus,
suggesting that this skin manifestation provides a highly specific but not very sensitive marker of MEN 2A or MTC within
families.
Despite the.se clinical similarities, our histological findings
were different: we failed to detect amyloid deposition despite
extensive analysis of biopsies in each patient, and we were at
first reluctant lo consider the diagnosis of FCLA in our patients.
However, several interpretations can be found for this discrepancy. First, analysis of the data of the other families (5,6,7,9)
showed that amyloid deposits have so far been found only in
adult women; similarly, an epidemiological study on CLA (13)
has reported a prevalence < 7% below 24 years old and a female:male ratio of 3:1. Thus sex and age factors in skin amyloidogenesis could explain our negative findings in two men
(III-10, III-l 1) and one young woman (IV-2). Another explanation can be provided by a current theory on skin amyloidogenesis: it is believed that scratching may play an important role in
amyloidogenesis by causing epidermal cell damage which leads
to filamentous degeneration of keratinocytes, subsequent apoptosis, and conversion of filamentous masses into amyloid material (14-16). Unlike some "friction amyloidosis" cases in which
scratching and hyperpigmentation were reporied to precede pruritus (17), the pruritus in the MEN 2A/familial MTC cases
seemed to be the first manifestation. The lack of amyloid in the
French patients could possibly be explained by the pruritus occurring first followed by scratching, which was not intense (IIIIO, III-l I) or of long enough duration (IV-2) to initiate significant amyloidogenesis.
However, three characteristics of the pruritic lesion associated with MEN 2A remain disturbing regarding the diagnosis of
FCLA. First, its topography is unusual: the main localizations of
lesions in other forins of CLA are legs, forearms, and back (18),
with lhe back lesions being rarely isolated. Of the three reports
of FCLA with exclusive back localizations (19-21) reviewed by
Gagel et al (6), only one (20) was isolated and unilateral. In that
report the skin lesions were clearly different than in MEN 2A
patients since they were already present at birth and not pmritic.
It should be stressed that the topography of the pruritus and skin
lesion associated with MEN 2A follows dermatomes C8-D3 in
the French patients (Fig 1) and apparently also in the other
FCLA/MEN 2A families (5-7). Second, in the French patients at
least, the pruritus is associated with hyperalgesia and paresthe-
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Fig 2—Scapular, unilateral pruritic skin lesion associated with
MEN 2A. Hyperpigmentation is common to all three patients
but more pronounced in patient III-IO (top photo). Papules
were seen only in patient fV-2 (bottom photo). Topography of
the lesion follows dermatomes C8-D3.

sia. In an epidemiological study on primary cutaneous amyloidosis, symptoms other than pmritus (buming sensations)
were reported only in 0.78% of patients (13). Third, the MEN
2A-associated pmritus is paroxysmal, suggesting a neurological
origin (22).
These three characteristics suggested a neurological cause for
the pruritus associated with MEN 2A. Based on this hypothesis
we reviewed the literature of localized pruritus of neurological
origin and identified an entity called notalgia paresthetica (NP).
NP refers to a neuropathy involving the dorsal primary divisions
of spinal nerves. It was first described in 1934 (23) and recendy
reviewed by Weber and Poulos (24), who extended the term to
several entities previously described as "localized pmritus"
(25), "puzzling posterior pigmented patches" (26), and "peculiar spotty pigmentation" (27). Most cases are sporadic, but one
family has been described (25). The main symptom of NP is pruritus, sometimes associated with hyperalgesia, buming, or tin-
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gling sensations, all localized unilaterally in the upper back at
the level of the first thoracic vertebra. In this area the neurological examination can reveal hypoesthesia to touch, hyperesthesia
to pinprick, and a reduced response to provoked sweating (24);
electromyogram has in some cases showed signs of denervation
(28). In the same area the patients also present with a skin lesion
consisting of a brown patch of macules and sometimes lichenified. Skin biopsies of the lesion show scattered keratinocytic necrosis, moderate acanthosis (when Hchenification is present),
and pigmentary incontinence. CLA is in the differential diagnosis of NP, but in NP there are no amyloid deposds in the papdlary dermis (27). Based on this description, we recalled our patients for neurological invesfigations and found only one pafient
(IV-2) who had hypoesthesia and pinprick hyperesthesia in the
area of the lesion, consistent with the diagnosis of NP.
We propose that the FCLA associated with MEN 2A could be
due to a hypothetic neurologic lesion of the thoracic sensory
nerves (similarto NP) which is responsible for pmritus, scratching, and eventually friction amyloidosis. This hypothesis bears
both theoretical and practical interests. Like the thyroid C-cells
and the adrenal medullary chromaffin cells, the sensory thoracic
nerves are derived from the neural crest (29). FCLA could then
be included with MTC and pheochromocytoma as a common
neurocristopathy resulting from the expression of a gene(s) located in the chromosome 10 pericentromeric region. From a
practical point of view, die recent report that local treatment
with capsaicin is effecfive in NP (30) suggests that a trial of capsaicin would be of interest in the symptomatic treatment of
FCLA associated with MEN 2A.
In order to test our hypothesis, we propose that the patients
presenting with FCLA associated with MEN 2A or MTC undergo a neurological examination possibly with electromyographic studies to search for sensory defects. In addifion, we
propose that patients presenting with familial NP be screened
for MEN 2A.
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